Lecanemab Three Years Post-Approval: A Comprehensive Multicenter, Real-World, Retrospective Study (LEADER) in Diverse US Clinical Settings
Copies of these presentations obtained through the QR code are for personal use only and may not be used without permission from AAIC and the authors of this presentation.
